TearClear: Detailed Company Information & Corporate Profile

Contact top employees from TearClear

Summary

TearClear is a private company that has been in the industry for 11 years. The business currently specializes in Pharmaceuticals, Pharmaceuticals areas. Srini Venkatesh is the Chief Executive Officer at the company. TearClear's headquarter is located at Copley, Ohio, USA. The number of employees is at least 1. Register with SignalHire to connect with TearClear employees and management.

TearClear Websitetearclear.com
Social Links
linkedIntwitterlinkedIn
Phone Number617-454-7251
Industries
TearClear Headquarters AddressBoston, MA, US
Company Size1-10 employees
DMA CodeCleveland Metropolitan Area
Founded2015
Estimated Annual Revenue$1 - 10M
Operating StatusIndependent Company
Updated:2026-08-27

Competitors

Name
Founded
Type
Employees
1998Public
Company
100 - 250
2011- 500-1000
2007- 100-200

Workforce Turnover

Contact top employees from TearClear
Srini Venkatesh
Srini VenkateshChief Executive Officer
Unlock contacts
Mike Williams
Mike WilliamsSenior Chemist
Unlock contacts

TearClear Corporate Information: FAQ

TearClear operates in the Pharma industries. More details can be found on the official website: tearclear.com.
TearClear has offices located in Boston, US.
The headquarters of TearClear are located in Boston, United States.
The current CEO of TearClear is Robert J Dempsey
You can contact TearClear by phone at 617-454-7251.
TearClear currently employs 1-10 people.
Well-known competitors of TearClear include Cytokinetics, Aimmune Therapeutics and SIRNAOMICS.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP